These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18704263)

  • 1. Antitumor activity of a novel series of alpha-aryloxy-alpha-methylhydrocinnamic acid derivatives as PPAR gamma agonists against a panel of human cancer cell lines.
    Xiong X; Ye Y; Fu L; Dai B; Liu J; Jia J; Tang J; Li L; Wang L; Shen J; Mei C
    Invest New Drugs; 2009 Jun; 27(3):223-32. PubMed ID: 18704263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrimidinyl-arylpropionic acid derivatives: viable resources in the development of new antineoplastic agents.
    Xiong X; Wang L; Ye Y; Fu L; Chen M; Wang Q; Liu M; Tang J; Dai B; Shen J; Mei C
    Invest New Drugs; 2010 Aug; 28(4):472-81. PubMed ID: 19533021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor efficacy of two novel non-thiazolidinedione compounds as peroxisome proliferator-activated receptor-gamma agonists in human osteosarcoma cells in vitro.
    Fu L; Xiong X; Wang L; Gao X; Ye Y; Jia J; Hu H; Li L; Shen J; Mei C
    Chemotherapy; 2009; 55(6):468-76. PubMed ID: 19996593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific thiazolidinediones inhibit ovarian cancer cell line proliferation and cause cell cycle arrest in a PPARγ independent manner.
    Al-Alem L; Southard RC; Kilgore MW; Curry TE
    PLoS One; 2011 Jan; 6(1):e16179. PubMed ID: 21283708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS; Chen WC; Bai X; Wang YD
    J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
    Yang FG; Zhang ZW; Xin DQ; Shi CJ; Wu JP; Guo YL; Guan YF
    Acta Pharmacol Sin; 2005 Jun; 26(6):753-61. PubMed ID: 15916743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor-gamma agonists cause growth arrest and apoptosis in human ovarian carcinoma cell lines.
    Yang YC; Tsao YP; Ho TC; Choung IP
    Int J Gynecol Cancer; 2007; 17(2):418-25. PubMed ID: 17316361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones.
    Weng JR; Chen CY; Pinzone JJ; Ringel MD; Chen CS
    Endocr Relat Cancer; 2006 Jun; 13(2):401-13. PubMed ID: 16728570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiazolidinediones/PPARγ agonists and fatty acid synthase inhibitors as an experimental combination therapy for prostate cancer.
    Mansour M; Schwartz D; Judd R; Akingbemi B; Braden T; Morrison E; Dennis J; Bartol F; Hazi A; Napier I; Abdel-Mageed AB
    Int J Oncol; 2011 Feb; 38(2):537-46. PubMed ID: 21170507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxy Cinnamic Acid Derivatives as Partial PPARγ Agonists: In silico Studies, Synthesis and Biological Characterization Against Chronic Myeloid Leukemia Cell Line (K562).
    Joshi H; Marulkar K; Gota V; Ramaa CS
    Anticancer Agents Med Chem; 2017; 17(4):524-541. PubMed ID: 27291250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.
    Magenta G; Borenstein X; Rolando R; Jasnis MA
    BMC Cancer; 2008 Feb; 8():47. PubMed ID: 18261208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor-gamma agonists suppress adrenocortical tumor cell proliferation and induce differentiation.
    Betz MJ; Shapiro I; Fassnacht M; Hahner S; Reincke M; Beuschlein F;
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3886-96. PubMed ID: 15886257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer properties of 4-thiazolidinone derivatives depend on peroxisome proliferator-activated receptor gamma (PPARγ).
    Szychowski KA; Leja ML; Kaminskyy DV; Kryshchyshyn AP; Binduga UE; Pinyazhko OR; Lesyk RB; Tobiasz J; Gmiński J
    Eur J Med Chem; 2017 Dec; 141():162-168. PubMed ID: 29031063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Design, synthesis, and PPARgamma agonistic activity of novel indenone derivatives].
    Qu LL; Ma YH
    Yao Xue Xue Bao; 2013 Apr; 48(4):508-13. PubMed ID: 23833937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth inhibition and differentiation induced by peroxisome proliferator activated receptor gamma ligand rosiglitazone in human melanoma cell line A375.
    Liu Y; Meng Y; Li H; Li J; Fu J; Liu Y; Chen XG
    Med Oncol; 2006; 23(3):393-402. PubMed ID: 17018897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-proliferative effect of rosiglitazone in the human T-lymphocyte leukaemia cell line Jurkat cells.
    Wei R; Yu F; Yang J; Gao H; Wang H; Hong T
    Cell Biol Int; 2018 May; 42(5):515-524. PubMed ID: 29274299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells.
    Aiello A; Pandini G; Frasca F; Conte E; Murabito A; Sacco A; Genua M; Vigneri R; Belfiore A
    Endocrinology; 2006 Sep; 147(9):4463-75. PubMed ID: 16777971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone attenuates insulin-like growth factor 1 receptor survival signaling in PC-3 cells.
    Papageorgiou E; Pitulis N; Manoussakis M; Lembessis P; Koutsilieris M
    Mol Med; 2008; 14(7-8):403-11. PubMed ID: 18475308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of ERalpha signalling pathway by PPARgamma agonists: evidences of PPARgamma-independent events in two hormone-dependent breast cancer cell lines.
    Lecomte J; Flament S; Salamone S; Boisbrun M; Mazerbourg S; Chapleur Y; Grillier-Vuissoz I
    Breast Cancer Res Treat; 2008 Dec; 112(3):437-51. PubMed ID: 18204896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
    Morosetti R; Servidei T; Mirabella M; Rutella S; Mangiola A; Maira G; Mastrangelo R; Koeffler HP
    Int J Oncol; 2004 Aug; 25(2):493-502. PubMed ID: 15254749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.